Distribution of Hepatitis C Virus Genotypes Among Chronic Infected Injecting Drug Users in Tehran, Iran

Author(s):
Fahimeh Ranjbar KermaniFahimeh Ranjbar KermaniFahimeh Ranjbar Kermani ORCID1, Zohreh SharifiZohreh SharifiZohreh Sharifi ORCID1,*, Fereshteh FerdowsianFereshteh FerdowsianFereshteh Ferdowsian ORCID1, Zahrah PazZahrah PazZahrah Paz ORCID1, Mahsa ZamanianMahsa ZamanianMahsa Zamanian ORCID1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran, [email protected]

Jundishapur Journal of Microbiology:Vol. 6, issue 3; 265-8
Published online:Apr 30, 2013
Article type:Research Article
Received:Apr 16, 2012
Accepted:Jul 02, 2012
How to Cite:Ranjbar Kermani F, Sharifi Z, Ferdowsian F, Paz Z, Zamanian M. Distribution of Hepatitis C Virus Genotypes Among Chronic Infected Injecting Drug Users in Tehran, Iran. Jundishapur J Microbiol. 2013;6(3):. doi: https://doi.org/10.5812/jjm.5191

Abstract

Background:

Hepatitis C virus (HCV) is the main cause of infection that has the potential to cause chronic liver disease. Injecting drug users (IDUs) have a key role in HCV transmission in Iran. Knowledge of the distribution of various genotypes is essential for successful future research and control strategies.

Objectives:

The aim of this study was to identify HCV genotypes among chronic infected injecting drug users (IDUs) in Tehran, Iran.

Patients and Methods:

In this cross sectional study, we investigated HCV genotypes among 36 plasma samples from HCV infected IDUs (35 male and 1female, mean age: 33.67, and age range 20-62 years), referred to Research Center of Iranian Blood Transfusion Organization(IBTO) in Tehran from December 2008 to March 2009.HCV Genotyping was performed using type-specific primers.

Results:

Genotypes 3a, 1a and 1b were found in 58.3 %, 25% and 16.7 % patients, respectively.

Conclusions:

Our study demonstrated the high prevalence of genotype 3a among injecting drug users, which is also found in Europe and United states.

Full Text

Full text is available in PDF

Similar Articles

25
Oct
2017

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Asaad Sharhani,
Yadollah Mehrabi,
Alireza Noroozi,
Maryam Nasirian,
Peter Higgs,
Ahmad Hajebi
,et al.

Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, et al. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10):e58739. doi: https://doi.org/10.5812/hepatmon.58739

31
Dec
2011

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Masoumeh Amin-Esmaeili,
Masoumeh Amin-Esmaeili,
Afarin Rahimi-Movaghar,
Afarin Rahimi-Movaghar,
Emran M. Razaghi,
Emran M. Razaghi
,et al.

Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806

8
Aug
2022
Hepat Mon

Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran

Mohammad Reza Hedayati-Moghaddam,
Majid Danaee,
Hossein Soltanian,
Seyed Ahmad Vahedi,
Arman Mosavat,
Maryam Shahi
,et al.

Hedayati-Moghaddam MR, Danaee M, Soltanian H, Vahedi SA, Mosavat A, et al. Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran. Hepat Mon. 2022;22(1):e127166. doi: https://doi.org/10.5812/hepatmon-127166

24
Jan
2021
Hepat Mon

Phylogenetic Analysis of NS5B Region of Hepatitis C Genotype 3a Virus among Different Risk Groups in Iran

Fahimeh Ranjbar Kermani,
Kamran Mousavi Hosseini,
Sedigheh Amini-Kafiabad,
Mahtab Maghsudlu,
Zohreh Sharifi,
Mohammad Ali Mansournia

Ranjbar Kermani F, Mousavi Hosseini K, Amini-Kafiabad S, Maghsudlu M, Sharifi Z, et al. Phylogenetic Analysis of NS5B Region of Hepatitis C Genotype 3a Virus among Different Risk Groups in Iran. Hepat Mon. 2020;20(12):e108936. doi: https://doi.org/10.5812/hepatmon.108936

18
Jan
2016

Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran

Hossein Norouzian,
Mohammadreza Gholami,
Pegah Shakib,
Gholamreza Goudarzi,
Hamze Ghobadian Diali,
Azam Rezvani

Norouzian H, Gholami M, Shakib P, Goudarzi G, Ghobadian Diali H, et al. Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict. 2016;5(1):e25028. doi: https://doi.org/10.5812/ijhrba.25028


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles